Our results demonstrate that Lkb1 is a critical regulator of BAT growth and function, and suggest that Lkb1 signalling may be therapeutically targeted to counteract obesity, diabetes and other metabolic diseases. Here, STK11 is linked to obesity due to melanocortin 4 receptor deficiency.